 |
|
|
| |
Pharmacokinetics of a simplified subcutaneous
lenacapavir regimen versus Phase 2/3 regimen
|
| |
| |
AIDS 2022 July 29-Aug 1 Montreal
Presenter
Vamshi Jogiraju
Authors
V. Jogiraju * (1), H. Graham (1), S. West (1), J. Ling (1), J. Cuvin (1), M. Rhee (1), R. Palaparthy (1), R. Singh (1)
Institutions
(1) Gilead Sciences, Inc., Foster City, United States
|
| |
|
|
|
|
|
